Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Delia Goletti

Showing results (1-10 of 310) with videos related to

Pageof 31
Sort By:
Expert Review of Anti-Infective Therapy|October 20, 2010
Do IFN-γ-release assays predict the risk of TB? New evidence from a study on patients with silicosisEnrico Girardi, Delia Goletti
The Journal of Rheumatology. Supplement|May 3, 2014
Biologics and tuberculosis risk: the rise and fall of an old disease and its new resurgenceFabrizio Cantini, Delia Goletti
Expert Review of Molecular Diagnostics|April 4, 2012
Screening for latent infection with Mycobacterium tuberculosis: a plea for targeted testing in low endemic regionsDelia Goletti, Martina Sester
The Journal of Rheumatology. Supplement|May 3, 2014
The spectrum of tuberculosis infection: new perspectives in the era of biologicsGiovanni Delogu, Delia Goletti
The New England Journal of Medicine|March 3, 2021
Baricitinib Therapy in Covid-19 Pneumonia - An Unmet Need FulfilledDelia Goletti, Fabrizio Cantini
Expert Review of Respiratory Medicine|May 19, 2010
Update on clinical research of tuberculosis: a report from the European Respiratory SocietyDelia Goletti, Giovanni Battista Migliori
The Journal of Rheumatology. Supplement|May 3, 2014
Adalimumab, etanercept, infliximab, and the risk of tuberculosis: data from clinical trials, national registries, and postmarketing surveillanceFabrizio Cantini, Laura Niccoli, Delia Goletti
The Journal of Rheumatology. Supplement|May 3, 2014
Tuberculosis risk in patients treated with non-anti-tumor necrosis factor-α (TNF-α) targeted biologics and recently licensed TNF-α inhibitors: data from clinical trials and national registriesFabrizio Cantini, Laura Niccoli, Delia Goletti
Expert Review of Molecular Diagnostics|August 10, 2023
Research tests for the diagnosis of tuberculosis infectionTonino Alonzi, Federica Repele, Delia Goletti
The European Respiratory Journal|January 18, 2020
Transcriptional biomarkers for predicting development of tuberculosis: progress and clinical considerationsHanif Esmail, Frank Cobelens, Delia Goletti
Pageof 31

Showing results (1-10 of 310) with videos related to

Sort By:
Pageof 31
Expert Review of Anti-Infective Therapy|October 20, 2010
Do IFN-γ-release assays predict the risk of TB? New evidence from a study on patients with silicosisEnrico Girardi, Delia Goletti
The Journal of Rheumatology. Supplement|May 3, 2014
Biologics and tuberculosis risk: the rise and fall of an old disease and its new resurgenceFabrizio Cantini, Delia Goletti
Expert Review of Molecular Diagnostics|April 4, 2012
Screening for latent infection with Mycobacterium tuberculosis: a plea for targeted testing in low endemic regionsDelia Goletti, Martina Sester
The Journal of Rheumatology. Supplement|May 3, 2014
The spectrum of tuberculosis infection: new perspectives in the era of biologicsGiovanni Delogu, Delia Goletti
The New England Journal of Medicine|March 3, 2021
Baricitinib Therapy in Covid-19 Pneumonia - An Unmet Need FulfilledDelia Goletti, Fabrizio Cantini
Expert Review of Respiratory Medicine|May 19, 2010
Update on clinical research of tuberculosis: a report from the European Respiratory SocietyDelia Goletti, Giovanni Battista Migliori
The Journal of Rheumatology. Supplement|May 3, 2014
Adalimumab, etanercept, infliximab, and the risk of tuberculosis: data from clinical trials, national registries, and postmarketing surveillanceFabrizio Cantini, Laura Niccoli, Delia Goletti
The Journal of Rheumatology. Supplement|May 3, 2014
Tuberculosis risk in patients treated with non-anti-tumor necrosis factor-α (TNF-α) targeted biologics and recently licensed TNF-α inhibitors: data from clinical trials and national registriesFabrizio Cantini, Laura Niccoli, Delia Goletti
Expert Review of Molecular Diagnostics|August 10, 2023
Research tests for the diagnosis of tuberculosis infectionTonino Alonzi, Federica Repele, Delia Goletti
The European Respiratory Journal|January 18, 2020
Transcriptional biomarkers for predicting development of tuberculosis: progress and clinical considerationsHanif Esmail, Frank Cobelens, Delia Goletti
Pageof 31